{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:25:50Z","timestamp":1794237950814,"version":"4.9.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["12563"],"award-info":[{"award-number":["12563"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["12563"],"award-info":[{"award-number":["12563"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2021,5,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Perturbations in circulating metabolites prior to a breast cancer diagnosis are not well characterised. We aimed to gain more detailed knowledge to help understand and prevent the disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Baseline plasma samples from 791 breast cancer cases and 791 matched controls from the E3N (EPIC-France) cohort were profiled by nuclear magnetic resonance (NMR)-based untargeted metabolomics. Partial least-squares discriminant analysis (PLS-DA) models were built from NMR profiles to predict disease outcome, and odds ratios and false discovery rate (FDR)-adjusted CIs were calculated for 43 identified metabolites by conditional logistic regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Breast cancer onset was predicted in the premenopausal subgroup with modest accuracy (AUC 0.61, 95% CI: 0.49\u20130.73), and 10 metabolites associated with risk, particularly histidine (OR\u2009=\u20091.70 per SD increase, FDR-adjusted CI 1.19\u20132.41), N-acetyl glycoproteins (OR\u2009=\u20091.53, FDR-adjusted CI 1.18\u20131.97), glycerol (OR\u2009=\u20091.55, FDR-adjusted CI 1.11\u20132.18) and ethanol (OR\u2009=\u20091.44, FDR-adjusted CI 1.05\u20131.97). No predictive capacity or significant metabolites were found overall or for postmenopausal women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Perturbed metabolism compared to controls was observed in premenopausal but not postmenopausal cases. Histidine and NAC have known involvement in inflammatory pathways, and the robust association of ethanol with risk suggests the involvement of alcohol intake.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41416-021-01304-1","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T10:03:28Z","timestamp":1615802608000},"page":"1734-1743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case\u2013control study nested within the French E3N cohort"],"prefix":"10.1038","volume":"124","author":[{"given":"Elodie","family":"Jobard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Dossus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Baglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Fornili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"L\u00e9cuyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Romana","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tr\u00e9dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Boutron-Ruault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Elena-Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Severi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6927-3360","authenticated-orcid":false,"given":"Joseph A.","family":"Rothwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"key":"1304_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. & Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"1304_CR2","unstructured":"Continuous Update Project Report: Diet, Nutrition, Physical Activity and Breast Cancer. Available at: wcrf.org\/breast-cancer-2017. All CUP reports are available at wcrf.org\/cupreports (2017)."},{"key":"1304_CR3","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/aje\/kwp257","volume":"170","author":"V Cottet","year":"2009","unstructured":"Cottet, V., Touvier, M., Fournier, A., Touillaud, M. S., Lafay, L., Clavel-Chapelon, F. et al. Postmenopausal breast cancer risk and dietary patterns in the E3N-EPIC prospective cohort study. Am. J. Epidemiol. 170, 1257\u20131267 (2009).","journal-title":"Am. J. Epidemiol."},{"key":"1304_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000103274","volume":"51","author":"E Kesse-Guyot","year":"2007","unstructured":"Kesse-Guyot, E., Bertrais, S., Duperray, B., Arnault, N., Bar-Hen, A., Galan, P. et al. Dairy products, calcium and the risk of breast cancer: results of the French SU.VI.MAX prospective study. Ann. Nutr. Metab. 51, 139\u2013145 (2007).","journal-title":"Ann. Nutr. Metab."},{"key":"1304_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/modpathol.3800255","volume":"18","author":"TC Putti","year":"2005","unstructured":"Putti, T. C., Abd El-Rehim, D. M., Rakha, E. A., Paish, C. E., Lee, A. H. S., Pinder, S. E. et al. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod. Pathol. 18, 26\u201335 (2005).","journal-title":"Mod. Pathol."},{"key":"1304_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ijc.20213","volume":"111","author":"B Tehard","year":"2004","unstructured":"Tehard, B., Lahmann, P. H., Riboli, E. & Clavel-Chapelon, F. Anthropometry, breast cancer and menopausal status: Use of repeated measurements over 10 years of follow-up - Results of the french E3N women\u2019s cohort study. Int J. Cancer 111, 264\u2013269 (2004).","journal-title":"Int J. Cancer"},{"key":"1304_CR7","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s11306-015-0793-8","volume":"11","author":"R Bro","year":"2015","unstructured":"Bro, R., Kamstrup-Nielsen, M. H., Engelsen, S. B., Savorani, F., Rasmussen, M. A., Hansen, L. et al. Forecasting individual breast cancer risk using plasma metabolomics and biocontours. Metabolomics 11, 1376\u20131380 (2015).","journal-title":"Metabolomics"},{"key":"1304_CR8","doi-asserted-by":"crossref","unstructured":"Kuhn, T., Floegel, A., Sookthai, D., Johnson, T., Rolle-Kampczyk, U., Otto, W. et al. Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. BMC Med. 14, 13 (2018).","DOI":"10.1186\/s12916-016-0552-3"},{"key":"1304_CR9","doi-asserted-by":"crossref","unstructured":"His, M., Viallon, V., Dossus, L., Gicquiau, A., Achaintre, D., Scalbert, A., et al. Prospective analysis of circulating metabolites and breast cancer in EPIC. BMC Med. 17, 178 (2019).","DOI":"10.1186\/s12916-019-1408-4"},{"key":"1304_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3945\/ajcn.116.150912","volume":"106","author":"MC Playdon","year":"2017","unstructured":"Playdon, M. C., Ziegler, R. G., Sampson, J. N., Stolzenberg-Solomon, R., Thompson, H. J., Irwin, M. L. et al. Nutritional metabolomics and breast cancer risk in a prospective study. Am. J. Clin. Nutr. 106, 637\u2013649 (2017).","journal-title":"Am. J. Clin. Nutr."},{"key":"1304_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ije\/dyx271","volume":"47","author":"L Lecuyer","year":"2018","unstructured":"Lecuyer, L., Bala, A. V., Deschasaux, M., Bouchemal, N., Triba, M. N., Vasson, M. P. et al. NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer. Int J. Epidemiol. 47, 484\u2013494 (2018).","journal-title":"Int J. Epidemiol."},{"key":"1304_CR12","first-page":"588","volume":"110","author":"SC Moore","year":"2018","unstructured":"Moore, S. C., Playdon, M. C., Sampson, J. N., Hoover, R. N., Trabert, B., Matthews, C. E. et al. A metabolomics analysis of body mass index and postmenopausal breast cancer risk. J. Natl Cancer Inst. 110, 588\u2013597 (2018).","journal-title":"J. Natl Cancer Inst."},{"key":"1304_CR13","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1158\/1055-9965.EPI-19-0154","volume":"28","author":"L Lecuyer","year":"2019","unstructured":"Lecuyer, L., Dalle, C., Lyan, B., Demidem, A., Rossary, A., Vasson, M. P. et al. Plasma metabolomic signatures associated with long-term breast cancer risk in the SU.VI.MAX prospective cohort. Cancer Epidemiol. Biomark. Prev. 28, 1300\u20131307 (2019).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"1304_CR14","first-page":"1008","volume":"83","author":"F Clavel-Chapelon","year":"1996","unstructured":"Clavel-Chapelon, F., Jadand, C., Goulard, H. & Guibout-Peigne, C. E3N, a cohort study on cancer risk factors in MGEN women. Description of protocol, main characteristics and population. Bull. Cancer 83, 1008\u20131013 (1996).","journal-title":"Bull. Cancer"},{"key":"1304_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/ije\/dyu184","volume":"44","author":"F Clavel-Chapelon","year":"2015","unstructured":"Clavel-Chapelon, F. Cohort profile: the French E3N cohort study. Int J. Epidemiol. 44, 801\u2013809 (2015).","journal-title":"Int J. Epidemiol."},{"key":"1304_CR16","first-page":"293","volume":"60","author":"C Guibout-Peigne","year":"2002","unstructured":"Guibout-Peigne, C., Prisse, N. & Clavel-Chapelon, F. A biological bank in an epidemiologic study in France: How? Example of the E3N-EPIC study. Ann. Biol. Clin. 60, 293\u2013298 (2002).","journal-title":"Ann. Biol. Clin."},{"key":"1304_CR17","unstructured":"Fages, A., Duarte-Salles, T., Stepien, M., Ferrari, P., Fedirko, V., Pontoizeau, C., et al. Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort. BMC Med 13, 242 (2015)."},{"key":"1304_CR18","doi-asserted-by":"crossref","unstructured":"Perrier, F., Novoloaca, A., Ambatipudi, S., Baglietto, L., Ghantous, A., Perduca, V., et al. Identifying and correcting epigenetics measurements for systematic sources of variation. Clin. Epigenetics 10, 38 (2018).","DOI":"10.1186\/s13148-018-0471-6"},{"key":"1304_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn, M. Building predictive models in R using the caret package. J. Stat. Softw. 28, 1\u201326 (2008).","journal-title":"J. Stat. Softw."},{"key":"1304_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1198\/016214504000001907","volume":"100","author":"Y Benjamini","year":"2005","unstructured":"Benjamini, Y. & Yekutieli, D. False discovery rate-adjusted multiple confidence intervals for selected parameters. J. Am. Stat. Assoc. 100, 71\u201381 (2005).","journal-title":"J. Am. Stat. Assoc."},{"key":"1304_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/jnci\/djk096","volume":"99","author":"MS Touillaud","year":"2007","unstructured":"Touillaud, M. S., Thiebaut, A. C. M., Fournier, A., Niravong, M., Boutron-Ruault, M. C. & Clavel-Chapelon, F. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J. Natl Cancer Inst. 99, 475\u2013486 (2007).","journal-title":"J. Natl Cancer Inst."},{"key":"1304_CR22","doi-asserted-by":"crossref","unstructured":"Jenkins, B. J., Seyssel, K., Chiu, S., Pan, P. H., Lin, S. Y., Stanley, E., et al. Odd chain fatty acids; new insights of the relationship between the gut microbiota, dietary intake, biosynthesis and glucose intolerance. Sci Rep 7, 44845 (2017).","DOI":"10.1038\/srep44845"},{"key":"1304_CR23","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S2213-8587(14)70146-9","volume":"2","author":"NG Forouhi","year":"2014","unstructured":"Forouhi, N. G., Koulman, A., Sharp, S. J., Imamura, F., Kroger, J., Schulze, M. B. et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol. 2, 810\u2013818 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1304_CR24","doi-asserted-by":"crossref","unstructured":"Fuertes-Martin, R., Correig, X., Vallve, J. C. & Amigo, N. Human serum\/plasma glycoprotein analysis by H-1-NMR, an emerging method of inflammatory assessment. J. Clin. Med. 9, 354 (2020).","DOI":"10.3390\/jcm9020354"},{"key":"1304_CR25","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.115.308078","volume":"118","author":"PR Lawler","year":"2016","unstructured":"Lawler, P. R., Akinkuolie, A. O., Chandler, P. D., Moorthy, M. V., Vandenburgh, M. J., Schaumberg, D. A. et al. Circulating N-linked glycoprotein acetyls and longitudinal mortality risk. Circ. Res. 118, 1106\u20131115 (2016).","journal-title":"Circ. Res."},{"key":"1304_CR26","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.4161\/cbt.5.11.3273","volume":"11","author":"V Medina","year":"2006","unstructured":"Medina, V., Cricco, G., Nunez, M., Martin, G., Mohamad, N., Correa-Fiz, F. et al. Histamine-mediated signaling processes in human malignant mammary cells. Cancer Biol. Ther. 11, 1462\u20131471 (2006).","journal-title":"Cancer Biol. Ther."},{"key":"1304_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3945\/ajcn.2008.26362","volume":"89","author":"JR Greenfield","year":"2009","unstructured":"Greenfield, J. R., Farooqi, I. S., Keogh, J. M., Henning, E., Habib, A. M., Blackwood, A. et al. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. Am. J. Clin. Nutr. 89, 106\u2013113 (2009).","journal-title":"Am. J. Clin. Nutr."},{"key":"1304_CR28","first-page":"1482","volume":"40","author":"D Bai","year":"2012","unstructured":"Bai, D. & Song, J. N. Study of metabolic biomarkers in plasma of patients with dyslipidemia based on gas chromatography-mass spectrometry and graphical models. Chin. J. Anal. Chem. 40, 1482\u20131487 (2012).","journal-title":"Chin. J. Anal. Chem."},{"key":"1304_CR29","doi-asserted-by":"crossref","unstructured":"Wang, Q., Ferreira, D. L. S., Nelson, S. M., Sattar, N., Ala-Korpela M. & Lawlor D. A. Metabolic characterization of menopause: cross-sectional and longitudinal evidence. BMC Med. 16, 17 (2018).","DOI":"10.1186\/s12916-018-1008-8"},{"key":"1304_CR30","doi-asserted-by":"crossref","unstructured":"Sun, Q., Xie, W., Wang, Y., Chong, F., Song, M. & Li T. et al. Alcohol consumption by beverage type and risk of breast cancer: a dose-response Meta-analysis of prospective cohort studies. Alcohol Alcohol 55, 246\u2013253.(2020).","DOI":"10.1093\/alcalc\/agaa012"},{"key":"1304_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/CEJ.0000000000000031","volume":"24","author":"G Fagherazzi","year":"2015","unstructured":"Fagherazzi, G., Vilier, A., Boutron-Ruault, M. C., Mesrine, S. & Clavel-Chapelon, F. Alcohol consumption and breast cancer risk subtypes in the E3N-EPIC cohort. Eur. J. Cancer Prev. 24, 209\u2013214 (2015).","journal-title":"Eur. J. Cancer Prev."},{"key":"1304_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrc2191","volume":"7","author":"HK Seitz","year":"2007","unstructured":"Seitz, H. K. & Stickel, F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat. Rev. Cancer 7, 599\u2013612 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"1304_CR33","doi-asserted-by":"crossref","unstructured":"van Roekel, E. H., Trijsburg, L., Assi, N., Carayol, M., Achaintre, D., Murphy, N. et al. Circulating metabolites associated with alcohol intake in the European Prospective Investigation into Cancer and Nutrition Cohort. Nutrients 10, 654 (2018).","DOI":"10.3390\/nu10050654"},{"key":"1304_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1161\/CIRCGENETICS.116.001444","volume":"9","author":"ME Lacruz","year":"2016","unstructured":"Lacruz, M. E., Kluttig, A., Tiller, D., Medenwald, D., Giegling, I., Rujescu, D. et al. Cardiovascular risk factors associated with blood metabolite concentrations and their alterations during a 4-year period in a population-based cohort. Circ. Cardiovasc. Genet. 9, 487\u2013494 (2016).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"1304_CR35","doi-asserted-by":"crossref","unstructured":"Jaremek, M., Yu, Z., Mangino, M., Mittelstrass, K., Prehn, C., Singmann, P. et al. Alcohol-induced metabolomic differences in humans. Transl. Psychiatry 3, e276 (2013).","DOI":"10.1038\/tp.2013.55"},{"key":"1304_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12199-015-0494-y","volume":"21","author":"S Harada","year":"2016","unstructured":"Harada, S., Takebayashi, T., Kurihara, A., Akiyama, M., Suzuki, A., Hatakeyama, Y. et al. Metabolomic profiling reveals novel biomarkers of alcohol intake and alcohol-induced liver injury in community-dwelling men. Environ. Health Prev. Med. 21, 18\u201326 (2016).","journal-title":"Environ. Health Prev. Med"},{"key":"1304_CR37","doi-asserted-by":"crossref","unstructured":"Pallister T., Jennings A., Mohney R. P., Yarand D., Mangino M., Cassidy A. et al. Characterizing blood metabolomics profiles associated with self-reported food intakes in female twins. PLoS ONE 11, e0158568 (2016).","DOI":"10.1371\/journal.pone.0158568"},{"key":"1304_CR38","doi-asserted-by":"crossref","unstructured":"Irwin, C., Van Reenen, M., Mason, S., Mienie, L. J., Wevers, R. A., Westerhuis, J. A., et al. The H-1-NMR-based metabolite profile of acute alcohol consumption: A metabolomics intervention study. PLoS ONE 13, e0196850 (2018).","DOI":"10.1371\/journal.pone.0196850"},{"key":"1304_CR39","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10552-014-0372-8","volume":"25","author":"AL Klatsky","year":"2014","unstructured":"Klatsky, A. L., Udaltsova, N., Li, Y., Baer, D., Tran, H. N. & Friedman, G. D. Moderate alcohol intake and cancer: the role of underreporting. Cancer Causes Control 25, 693\u2013699 (2014).","journal-title":"Cancer Causes Control"},{"key":"1304_CR40","doi-asserted-by":"crossref","unstructured":"Carayol, M., Licaj, I., Achaintre, D., Sacerdote, C., Vineis, P., Key, T. J. et al. Reliability of serum metabolites over a two-year period: a targeted metabolomic approach in fasting and non-fasting samples from EPIC. PLoS ONE 10, e0135437 (2015).","DOI":"10.1371\/journal.pone.0135437"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-021-01304-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-021-01304-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-021-01304-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:09:29Z","timestamp":1684616969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01304-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,5,11]]}},"alternative-id":["1304"],"URL":"https:\/\/doi.org\/10.1038\/s41416-021-01304-1","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"16 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The E3N cohort was granted ethical approval by the French National Commission for Computed Data and Individual Freedom (<i>Commission Nationale de l\u2019Informatique et des Libert\u00e9s<\/i>) and all E3N participants provided written consent for the use of their blood samples and all data. The study was performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Data are available from the corresponding author upon reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was funded through the LYriCAN grant from INCa-DGOS-Inserm (Grant No. 12563).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}